Source: Webindia123

DiabetOmics: DiabetOmics launches Lumella, first-of-its-kind, rapid, point-of-care test for preeclampsia assessment

Preeclampsia, characterized as a hypertensive disorder, is an undesirable complication in pregnancy and can affect both the mother and the baby. It is a complex disease and affects multiple organs and systems in the pregnant woman.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Srinivasa Nagalla's photo - President & CEO of Diabetomics

President & CEO

Srinivasa Nagalla

CEO Approval Rating

87/100

Read more